Additionally, paste this code immediately after the opening tag:

Order a free catalogue!








Inauguration of HealthTech program with SiDLY

On 19 April in The Heart of Warsaw was a conference inaugurating the project HelthTech. The Heart Warsaw together with AbbVie, an international pharmaceutical corporation, launch a program to link medical startup projects with the largest medical companies.

The program is divided into three most prospective development areas: telemedicine, medical data management and internet medical stuff. Edyta Kocyk, CEO of SiDLY, was invited to the inaugural panel as a successful startup in the telemedicine field. The exchange of opinions and experience between Ernst & Young, Abbvie and the startups: SiDLY and Braster brought interesting proposals about develop startup partnerships with corporations – not only in investment, but also in distribution, marketing and sales areas. Projects such as SiDLY Care may use not only among individual consumers, but also increase safety and minimize risk in manufacturing companies among workers performing high-risk profession, pharmaceutical companies diversify the offer and allow the corporation to enter the growing market intensively the senior telecare.

More details about project: http://www.theheart.tech/scaleups/#healthtech-program-telemedici-450.


Sidly Ltd. implements a project co-financed from European Funds “Foreign promotion of the Sidly Care multisensory device for remote medical care”

The aim of the project is to increase the competitiveness and visibility of Sidly Ltd. and its innovative product SiDLY Care – a multisensory device for remote medical care in the forms of promotion related to market events specified in the Program for the promotion of the medical equipment industry.

Project value:1 162 350,00 PLN
Co-financing from the European Union: 756 000,00 PLN
Project implementation period: 14.03.2017 – 31.12.2019r.

Project goals – to develop a telemedicine prototype system for continuous heart rate monitoring

Project research results will be implemented in the Company’s operations, and the cardiac dysfunction detection system, developed as part of the project, will be introduced to the Company’s offer next to the current product.

project value: – 3 364 840,00 PLN
contribution of European Funds : – 2 493 088,00 PLN

Website co-financed from the European Regional Development Fund under the Intelligent Development Operational Program 2014-2020, Measure 3.3 “Support for the promotion and internationalization of innovative enterprises”